Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25.59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […]

Related Keywords

United States , ,Charles Schwab Investment Management Inc ,Deciphera Pharmaceuticals Price Performance ,Institutional Trading Of Deciphera Pharmaceuticals ,Deciphera Pharmaceuticals ,Deciphera Pharmaceuticals Inc ,Principal Financial Group Inc ,Jefferies Financial Group ,Deciphera Pharmaceuticals Company Profile ,Deutsche Bank ,Jpmorgan Chase Co ,Nasdaq ,News Ratings For Deciphera Pharmaceuticals Daily ,Get Free Report ,Financial Group ,Schwab Investment Management ,Investment Management ,Dark Forest Capital Management ,Forest Capital Management ,Deciphera Pharmaceuticals Daily ,